Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for CPRX

Stock Name	Catalyst Pharmaceuticals Inc
Ticker	CPRX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US14888U1016
LEI	5299004O0R5XXLA5H544

Show aggregate CPRX holdings

News associated with CPRX

Mutual of America Capital Management LLC Sells 657 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Mutual of America Capital Management LLC lessened its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 3.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,327 shares of the biopharmaceutical company’s stock after selling 657 shares during the quarter. Mutual of America […] - 2025-08-13 05:45:09
Maryland State Retirement & Pension System Sells 4,969 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Maryland State Retirement & Pension System lowered its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 13.2% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 32,706 shares of the biopharmaceutical company’s stock after selling 4,969 shares during the period. Maryland State Retirement & […] - 2025-08-13 05:06:50
Wall Street Zen Downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to Hold: Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was downgraded by Wall Street Zen from a “strong-buy” rating to a “hold” rating in a research report issued on Saturday. Separately, Cantor Fitzgerald raised shares of Catalyst Pharmaceuticals to a “strong-buy” rating in a research report on Thursday, June 5th. One investment analyst has rated the stock […] - 2025-08-11 05:44:53
Zurcher Kantonalbank Zurich Cantonalbank Has $774,000 Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 11.3% in the first quarter, Holdings Channel.com reports. The firm owned 31,897 shares of the biopharmaceutical company’s stock after acquiring an additional 3,244 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Catalyst Pharmaceuticals were worth […] - 2025-08-06 06:08:49
Federated Hermes Inc. Decreases Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Federated Hermes Inc. decreased its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 57.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 74,484 shares of the biopharmaceutical company’s stock after selling 99,906 shares during the quarter. Federated Hermes Inc. owned […] - 2025-08-06 05:12:59
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $32.83 Consensus Target Price from Brokerages: Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have been given an average recommendation of “Buy” by the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average […] - 2025-07-25 05:48:50
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Holdings Lifted by New York State Common Retirement Fund: New York State Common Retirement Fund grew its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 155.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 92,001 shares of the biopharmaceutical company’s stock after purchasing an additional 55,968 shares during […] - 2025-07-24 04:40:46
Alps Advisors Inc. Reduces Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Alps Advisors Inc. lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 3.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,476 shares of the biopharmaceutical company’s stock after selling 633 shares during the […] - 2025-07-15 06:26:34
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Oregon Public Employees Retirement Fund: Oregon Public Employees Retirement Fund lessened its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 25,639 shares of the biopharmaceutical company’s stock after selling 705 shares during the period. Oregon Public Employees Retirement Fund’s holdings in […] - 2025-07-08 05:24:52
Wealth Enhancement Advisory Services LLC Grows Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Wealth Enhancement Advisory Services LLC increased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 65.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 35,334 shares of the biopharmaceutical company’s stock after acquiring an additional 13,915 shares during the quarter. Wealth […] - 2025-07-03 04:26:50
Oppenheimer & Co. Inc. Lowers Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Oppenheimer & Co. Inc. decreased its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 5.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 98,746 shares of the biopharmaceutical company’s stock after selling 5,741 shares during the period. Oppenheimer & […] - 2025-06-27 05:48:55
XML Financial LLC Sells 20,000 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): XML Financial LLC cut its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 66.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,000 shares of the biopharmaceutical company’s stock after selling 20,000 shares during the […] - 2025-06-25 05:35:06
Sound Income Strategies LLC Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Sound Income Strategies LLC acquired a new stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm acquired 2,654 shares of the biopharmaceutical company’s stock, valued at approximately $64,000. Other hedge funds and other institutional investors have also recently made changes to their positions in the […] - 2025-06-17 05:26:52
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Holdings Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC: UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 11.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 263,905 shares of the biopharmaceutical company’s […] - 2025-06-03 05:13:09
Mackenzie Financial Corp Grows Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Mackenzie Financial Corp boosted its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 132.9% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 34,531 shares of the biopharmaceutical company’s stock after buying an additional 19,705 shares during the quarter. Mackenzie Financial Corp’s holdings in Catalyst Pharmaceuticals were worth $721,000 at […] - 2025-06-02 05:49:04
Tidal Investments LLC Reduces Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Tidal Investments LLC trimmed its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,141 shares of the biopharmaceutical company’s stock after selling 1,905 shares during the period. Tidal Investments […] - 2025-05-27 05:22:56
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 3.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 68,252 shares of the biopharmaceutical company’s stock after buying an additional 2,252 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Catalyst Pharmaceuticals […] - 2025-05-25 07:56:51
BNP Paribas Financial Markets Has $2.67 Million Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): BNP Paribas Financial Markets cut its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 16.7% during the 4th quarter, Holdings Channel reports. The firm owned 127,679 shares of the biopharmaceutical company’s stock after selling 25,571 shares during the quarter. BNP Paribas Financial Markets’ holdings in Catalyst Pharmaceuticals were worth $2,665,000 as […] - 2025-05-16 05:24:51
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Holdings Lowered by The Manufacturers Life Insurance Company: The Manufacturers Life Insurance Company reduced its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,366 shares of the biopharmaceutical company’s stock after selling 1,444 shares during the quarter. The Manufacturers […] - 2025-05-13 05:26:56
Envestnet Asset Management Inc. Acquires 39,836 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Envestnet Asset Management Inc. lifted its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 162.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,395 shares of the biopharmaceutical company’s stock after purchasing an additional 39,836 shares during the quarter. Envestnet […] - 2025-04-30 04:27:02
Barclays PLC Sells 4,035 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Barclays PLC lessened its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 1.6% in the 4th quarter, Holdings Channel reports. The firm owned 244,423 shares of the biopharmaceutical company’s stock after selling 4,035 shares during the period. Barclays PLC’s holdings in Catalyst Pharmaceuticals were worth $5,101,000 at the end of the most recent […] - 2025-04-27 05:54:51
Raymond James Financial Inc. Invests $6.89 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Raymond James Financial Inc. acquired a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 329,980 shares of the biopharmaceutical company’s stock, valued at approximately $6,887,000. Several other hedge funds have […] - 2025-04-24 04:41:07
Summit Investment Advisors Inc. Boosts Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Summit Investment Advisors Inc. grew its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 5.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 11,696 shares of the biopharmaceutical company’s stock after buying an additional 580 shares during the period. Summit Investment Advisors Inc.’s holdings in Catalyst Pharmaceuticals were worth […] - 2025-04-22 05:47:00
Cerity Partners LLC Has $548,000 Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Cerity Partners LLC decreased its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 7.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 26,482 shares of the biopharmaceutical company’s stock after selling 2,251 shares during the period. Cerity Partners LLC’s holdings in Catalyst Pharmaceuticals were worth $548,000 as of its most […] - 2025-04-22 04:50:54
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Russell Investments Group Ltd.: Russell Investments Group Ltd. increased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 1.4% during the fourth quarter, Holdings Channel reports. The fund owned 176,259 shares of the biopharmaceutical company’s stock after purchasing an additional 2,471 shares during the quarter. Russell Investments Group Ltd.’s holdings in Catalyst Pharmaceuticals were worth $3,679,000 as […] - 2025-04-16 05:06:59
Analysts Set Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Price Target at $32.29: Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have earned a consensus rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target […] - 2025-04-14 03:01:01
Corebridge Financial Inc. Cuts Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Corebridge Financial Inc. lessened its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 7.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,539 shares of the biopharmaceutical company’s stock after selling 4,627 shares during the period. Corebridge Financial Inc.’s holdings in […] - 2025-04-04 05:10:55
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Holdings Boosted by Commonwealth Equity Services LLC: Commonwealth Equity Services LLC raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 133.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,331 shares of the biopharmaceutical company’s stock after acquiring an additional 22,455 shares during the period. […] - 2025-04-03 04:20:49
KLP Kapitalforvaltning AS Invests $772,000 in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): KLP Kapitalforvaltning AS bought a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 37,000 shares of the biopharmaceutical company’s stock, valued at approximately $772,000. Several other hedge funds and other institutional […] - 2025-04-01 05:17:01
Cibc World Markets Corp Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): Cibc World Markets Corp bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 10,463 shares of the biopharmaceutical company’s stock, valued at approximately $218,000. A number of other hedge funds have also bought and sold shares of the stock. Steward Partners […] - 2025-03-27 06:54:57

iShares Healthcare Innovation UCITS ETF USD (Acc) CPRX holdings

Date	Number of CPRX Shares Held	Base Market Value of CPRX Shares	Local Market Value of CPRX Shares	Change in CPRX Base Value	Current Price per CPRX Share Held	Previous Price per CPRX Share Held
2025-11-11 (Tuesday)	147,830	USD 3,414,873	USD 3,414,873	USD 227,658	USD 23.1	USD 21.56
2025-11-10 (Monday)	147,830	USD 3,187,215	USD 3,187,215	USD 25,131	USD 21.56	USD 21.39
2025-11-07 (Friday)	147,830	USD 3,162,084	USD 3,162,084	USD 59,132	USD 21.39	USD 20.99
2025-11-06 (Thursday)	147,830	USD 3,102,952	USD 3,102,952	USD -57,653	USD 20.99	USD 21.38
2025-11-05 (Wednesday)	147,830	USD 3,160,605	USD 3,160,605	USD 5,913	USD 21.38	USD 21.34
2025-11-04 (Tuesday)	147,830	USD 3,154,692	USD 3,154,692	USD -14,783	USD 21.34	USD 21.44
2025-11-03 (Monday)	147,830	USD 3,169,475	USD 3,169,475	USD 25,131	USD 21.44	USD 21.27
2025-10-31 (Friday)	147,830	USD 3,144,344	USD 3,144,344	USD 44,349	USD 21.27	USD 20.97
2025-10-30 (Thursday)	147,830	USD 3,099,995	USD 3,099,995	USD -5,913	USD 20.97	USD 21.01
2025-10-29 (Wednesday)	147,830	USD 3,105,908	USD 3,105,908	USD -51,741	USD 21.01	USD 21.36
2025-10-28 (Tuesday)	147,830	USD 3,157,649	USD 3,157,649	USD -4,435	USD 21.36	USD 21.39
2025-10-27 (Monday)	147,830	USD 3,162,084	USD 3,162,084	USD 63,567	USD 21.39	USD 20.96

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CPRX by Blackrock for IE00BYZK4776

Show aggregate share trades of CPRX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -1,256 20.960 21.150 21.131 USD -26,541 22.41 Profit of 1,607 on sale
2025-09-11 BUY 629 20.250 20.310 20.304 USD 12,771 22.65
2025-07-08 SELL -628 20.750 21.250 21.200 USD -13,314 22.83 Profit of 1,021 on sale
2025-06-24 SELL -631 22.070 22.540 22.493 USD -14,193 22.91 Profit of 261 on sale
2025-06-23 SELL -631 22.120 22.720 22.660 USD -14,298 22.91 Profit of 159 on sale
2025-06-20 BUY 4,968 22.480 23.110 23.047 USD 114,497 22.92
2025-06-11 SELL -608 25.410 26.500 26.391 USD -16,046 22.87 Loss of -2,138 on sale
2025-05-30 SELL -608 24.960 25.230 25.203 USD -15,323 22.71 Loss of -1,518 on sale
2025-05-21 BUY 608 24.320 24.700 24.662 USD 14,994 22.60
2025-05-14 SELL -3,648 23.400 24.070 24.003 USD -87,563 22.54 Loss of -5,325 on sale
2025-04-30 SELL -608 24.290 24.610 24.578 USD -14,943 22.42 Loss of -1,312 on sale
2025-04-28 SELL -608 23.630 24.190 24.134 USD -14,673 22.39 Loss of -1,061 on sale
2025-04-25 SELL -608 23.450 23.510 23.504 USD -14,290 22.38 Loss of -684 on sale
2025-04-11 SELL -3,666 22.050 22.140 22.131 USD -81,132 22.35 Profit of 811 on sale
2025-04-08 SELL -1,827 21.400 23.160 22.984 USD -41,992 22.37 Loss of -1,123 on sale
2025-04-07 SELL -1,262 21.810 22.930 22.818 USD -28,796 22.38 Loss of -558 on sale
2025-03-31 SELL -1,218 24.250 24.500 24.475 USD -29,811 22.30 Loss of -2,649 on sale
2025-03-21 SELL -1,218 24.230 24.480 24.455 USD -29,786 22.08 Loss of -2,890 on sale
2025-03-17 BUY 3,861 21.810 21.840 21.837 USD 84,313 22.06
2025-03-12 SELL -598 21.200 21.420 21.398 USD -12,796 22.11 Profit of 425 on sale
2025-02-28 SELL -598 22.890 22.900 22.899 USD -13,694 22.15 Loss of -449 on sale
2025-02-25 BUY 598 20.800 21.510 21.439 USD 12,821 22.21
2025-02-20 SELL -598 22.050 22.550 22.500 USD -13,455 22.24 Loss of -157 on sale
2025-02-19 BUY 1,194 22.530 22.800 22.773 USD 27,191 22.23
2025-02-18 BUY 597 22.930 23.590 23.524 USD 14,044 22.22
2024-12-30 SELL -1,175 21.070 21.360 21.331 USD -25,064 21.87 Profit of 637 on sale
2024-12-06 SELL -592 22.020 22.080 22.074 USD -13,068 21.86 Loss of -124 on sale
2024-12-04 SELL -592 21.960 22.060 22.050 USD -13,054 21.87 Loss of -108 on sale
2024-12-03 SELL -1,186 21.710 22.590 22.502 USD -26,687 21.87 Loss of -746 on sale
2024-11-21 SELL -597 21.120 21.210 21.201 USD -12,657 21.87 Profit of 401 on sale
2024-11-20 SELL -605 21.150 21.630 21.582 USD -13,057 21.91 Profit of 200 on sale
2024-11-19 SELL -605 21.390 21.390 21.390 USD -12,941 21.94 Profit of 335 on sale
2024-11-18 SELL -2,376 20.820 21.190 21.153 USD -50,260 22.01 Profit of 2,044 on sale
2024-11-12 SELL -594 23.040 23.730 23.661 USD -14,055 21.94 Loss of -1,020 on sale
2024-11-07 SELL -594 23.250 24.210 24.114 USD -14,324 21.69 Loss of -1,439 on sale
2024-11-05 SELL -1,188 21.960 22.050 22.041 USD -26,185 21.57 Loss of -554 on sale
2024-10-28 SELL -594 21.860 22.200 22.166 USD -13,167 21.34 Loss of -492 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-1,256	20.960	21.150	21.131	USD -26,541	22.41 Profit of 1,607 on sale
2025-09-11	BUY	629	20.250	20.310	20.304	USD 12,771	22.65
2025-07-08	SELL	-628	20.750	21.250	21.200	USD -13,314	22.83 Profit of 1,021 on sale
2025-06-24	SELL	-631	22.070	22.540	22.493	USD -14,193	22.91 Profit of 261 on sale
2025-06-23	SELL	-631	22.120	22.720	22.660	USD -14,298	22.91 Profit of 159 on sale
2025-06-20	BUY	4,968	22.480	23.110	23.047	USD 114,497	22.92
2025-06-11	SELL	-608	25.410	26.500	26.391	USD -16,046	22.87 Loss of -2,138 on sale
2025-05-30	SELL	-608	24.960	25.230	25.203	USD -15,323	22.71 Loss of -1,518 on sale
2025-05-21	BUY	608	24.320	24.700	24.662	USD 14,994	22.60
2025-05-14	SELL	-3,648	23.400	24.070	24.003	USD -87,563	22.54 Loss of -5,325 on sale
2025-04-30	SELL	-608	24.290	24.610	24.578	USD -14,943	22.42 Loss of -1,312 on sale
2025-04-28	SELL	-608	23.630	24.190	24.134	USD -14,673	22.39 Loss of -1,061 on sale
2025-04-25	SELL	-608	23.450	23.510	23.504	USD -14,290	22.38 Loss of -684 on sale
2025-04-11	SELL	-3,666	22.050	22.140	22.131	USD -81,132	22.35 Profit of 811 on sale
2025-04-08	SELL	-1,827	21.400	23.160	22.984	USD -41,992	22.37 Loss of -1,123 on sale
2025-04-07	SELL	-1,262	21.810	22.930	22.818	USD -28,796	22.38 Loss of -558 on sale
2025-03-31	SELL	-1,218	24.250	24.500	24.475	USD -29,811	22.30 Loss of -2,649 on sale
2025-03-21	SELL	-1,218	24.230	24.480	24.455	USD -29,786	22.08 Loss of -2,890 on sale
2025-03-17	BUY	3,861	21.810	21.840	21.837	USD 84,313	22.06
2025-03-12	SELL	-598	21.200	21.420	21.398	USD -12,796	22.11 Profit of 425 on sale
2025-02-28	SELL	-598	22.890	22.900	22.899	USD -13,694	22.15 Loss of -449 on sale
2025-02-25	BUY	598	20.800	21.510	21.439	USD 12,821	22.21
2025-02-20	SELL	-598	22.050	22.550	22.500	USD -13,455	22.24 Loss of -157 on sale
2025-02-19	BUY	1,194	22.530	22.800	22.773	USD 27,191	22.23
2025-02-18	BUY	597	22.930	23.590	23.524	USD 14,044	22.22
2024-12-30	SELL	-1,175	21.070	21.360	21.331	USD -25,064	21.87 Profit of 637 on sale
2024-12-06	SELL	-592	22.020	22.080	22.074	USD -13,068	21.86 Loss of -124 on sale
2024-12-04	SELL	-592	21.960	22.060	22.050	USD -13,054	21.87 Loss of -108 on sale
2024-12-03	SELL	-1,186	21.710	22.590	22.502	USD -26,687	21.87 Loss of -746 on sale
2024-11-21	SELL	-597	21.120	21.210	21.201	USD -12,657	21.87 Profit of 401 on sale
2024-11-20	SELL	-605	21.150	21.630	21.582	USD -13,057	21.91 Profit of 200 on sale
2024-11-19	SELL	-605	21.390	21.390	21.390	USD -12,941	21.94 Profit of 335 on sale
2024-11-18	SELL	-2,376	20.820	21.190	21.153	USD -50,260	22.01 Profit of 2,044 on sale
2024-11-12	SELL	-594	23.040	23.730	23.661	USD -14,055	21.94 Loss of -1,020 on sale
2024-11-07	SELL	-594	23.250	24.210	24.114	USD -14,324	21.69 Loss of -1,439 on sale
2024-11-05	SELL	-1,188	21.960	22.050	22.041	USD -26,185	21.57 Loss of -554 on sale
2024-10-28	SELL	-594	21.860	22.200	22.166	USD -13,167	21.34 Loss of -492 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CPRX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	276,998	17,064	585,946	47.3%
2025-09-18	273,542	6	654,965	41.8%
2025-09-17	145,783	207	420,085	34.7%
2025-09-16	345,623	36	799,715	43.2%
2025-09-15	359,350	11	711,698	50.5%
2025-09-12	263,666	500	503,801	52.3%
2025-09-11	397,628	1	644,183	61.7%
2025-09-10	483,754	1,022	823,394	58.8%
2025-09-09	423,631	452	684,241	61.9%
2025-09-08	630,823	27	1,059,112	59.6%
2025-09-05	600,683	0	965,915	62.2%
2025-09-04	356,644	15,054	1,095,127	32.6%
2025-09-03	440,819	17,026	1,088,956	40.5%
2025-09-02	227,689	0	675,527	33.7%
2025-08-29	168,891	0	266,913	63.3%
2025-08-28	212,441	0	580,558	36.6%
2025-08-27	227,336	741	631,548	36.0%
2025-08-26	272,786	6	696,066	39.2%
2025-08-25	485,951	12	909,182	53.4%
2025-08-22	129,020	0	392,215	32.9%
2025-08-21	126,740	98	346,773	36.5%
2025-08-20	89,442	0	222,181	40.3%
2025-08-19	123,281	0	333,823	36.9%
2025-08-18	128,299	365	525,066	24.4%
2025-08-15	104,084	0	467,701	22.3%
2025-08-14	121,554	798	465,526	26.1%
2025-08-13	109,173	498	355,509	30.7%
2025-08-12	115,102	1,009	365,784	31.5%
2025-08-11	221,795	1,832	606,250	36.6%
2025-08-08	336,254	18,147	879,547	38.2%
2025-08-07	787,970	72,754	1,873,826	42.1%
2025-08-06	468,055	12	661,206	70.8%
2025-08-05	320,436	1,415	590,589	54.3%
2025-08-04	146,246	0	335,588	43.6%
2025-08-01	159,717	0	320,350	49.9%
2025-07-31	200,956	758	314,180	64.0%
2025-07-30	252,238	300	439,849	57.3%
2025-07-29	343,373	514	567,800	60.5%
2025-07-28	331,906	578	493,046	67.3%
2025-07-25	187,765	36	341,486	55.0%
2025-07-24	162,812	0	272,748	59.7%
2025-07-23	369,646	2,352	683,180	54.1%
2025-07-22	270,462	2,750	511,954	52.8%
2025-07-21	232,692	0	404,214	57.6%
2025-07-18	283,718	450	390,368	72.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE